Previous Close | 35.11 |
Open | 34.84 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's Range | 34.53 - 34.84 |
52 Week Range | 23.72 - 37.57 |
Volume | |
Avg. Volume | 198,820 |
Market Cap | 67.385B |
Beta (5Y Monthly) | 0.26 |
PE Ratio (TTM) | 52.32 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | 0.24 (0.70%) |
Ex-Dividend Date | Sept 28, 2023 |
1y Target Est | N/A |
BASKING RIDGE, N.J., May 21, 2024--Daiichi Sankyo Highlights Progress in Creating New Standards of Care for Patients Across Multiple Cancers at ASCO
TOKYO & BASKING RIDGE, N.J., April 29, 2024--ENHERTU Showed Statistically Significant & Clinically Meaningful Improvement in PFS in HR Positive, HER2 Low mBC Following ET in DESTINY-Breast06
TOKYO & BASKING RIDGE, N.J., April 06, 2024--ENHERTU® Approved in the U.S. as First Tumor Agnostic HER2 Directed Therapy for Previously Treated Patients with Metastatic HER2+ Solid Tumors